Sodium‐glucose co‐transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician

AIMS: Sodium‐glucose co‐transporter type 2 (SGLT2) inhibitors are a new class of anti‐hyperglycaemic agents in type 2 diabetes mellitus (T2DM). This review examines their mechanism of action and provides an overview of safety and efficacy from the main studies of SGLT2 inhibitors marketed in the Uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Dandona, Paresh, Chaudhuri, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518299/
https://www.ncbi.nlm.nih.gov/pubmed/28440009
http://dx.doi.org/10.1111/ijcp.12937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518299/
https://www.ncbi.nlm.nih.gov/pubmed/28440009
http://dx.doi.org/10.1111/ijcp.12937

Ejemplares similares